中国成人胰岛素抵抗与β细胞功能障碍与新发糖尿病的关联:全国性人群前瞻性队列研究
该全国性人群前瞻性队列纳入94952名40岁及以上成人,分析胰岛素抵抗(HOMA-IR)和β细胞功能障碍(HOMA-B)与新发糖尿病的关联。结果显示高HOMA-IR与糖尿病的风险比高于低HOMA-B,约24.4%的新发糖尿病可归因于胰岛素抵抗,12.4%归因于β细胞功能障碍,且肥胖可修饰上述关联。
要点
- HOMA-IR最高四分位组较最低组糖尿病风险HR为6.70(95%CI 6.08-7.39)。
- HOMA-B最低四分位组较最高组糖尿病风险HR为4.08(95%CI 3.72-4.48)。
- 约24.4%新发糖尿病归因于胰岛素抵抗,12.4%归因于β细胞功能障碍。
核心结论
- 在中国成人中,胰岛素抵抗与新发糖尿病的关联强于β细胞功能障碍,且该关联模式在肥胖成人中更突出。
- 鉴于HOMA指数作为胰岛素抵抗和β细胞功能障碍替代指标的局限性,这些发现应谨慎解读。
研究设计与样本
- 全国性、人群基础、前瞻性队列研究,分析中国心脏代谢疾病与癌症队列研究数据。
- 2011-12年基线招募40岁及以上成人,2014-16年随访。
- 排除基线糖尿病、基线糖耐量状态缺失、基线HOMA指数缺失、基线协变量缺失及随访糖耐量状态缺失者。
- 最终纳入94952名参与者(男31517名,女63435名)。
- 糖耐量状态及糖尿病前期按美国糖尿病协会2010标准定义。
主要发现
- 高HOMA-IR与新发糖尿病风险升高相关:四分位4 vs 1的HR为6.70(95%CI 6.08-7.39);Z评分每增加1单位HR为2.17(95%CI 2.10-2.24)。
- 低HOMA-B与新发糖尿病风险升高相关:四分位1 vs 4的HR为4.08(95%CI 3.72-4.48);Z评分每降低1单位HR为1.92(95%CI 1.85-2.00)。
- 约24.4%(95%CI 23.6-25.2)的新发糖尿病可归因于胰岛素抵抗,12.4%(95%CI 11.2-13.7)可归因于β细胞功能障碍。
- 正常体重者中,HOMA-IR的Z评分每增加1单位糖尿病HR为1.83(95%CI 1.72-1.95),HOMA-B的Z评分每降低1单位HR为2.03(95%CI 1.86-2.21)。
- 肥胖者中,HOMA-IR的Z评分每增加1单位糖尿病HR为2.02(95%CI 1.93-2.11),HOMA-B的Z评分每降低1单位HR为1.88(95%CI 1.79-1.98);交互作用P=0.0091。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- HOMA指数作为胰岛素抵抗和β细胞功能障碍的替代指标存在局限性,原文结论指出这些发现应谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: National investigations on the interaction of insulin resistance, β-cell dysfunction, and obesity with the development of diabetes are scarce in China. We aimed to investigate the individual and joint associations of insulin resistance and β-cell dysfunction with incident diabetes, and to examine the modifying effect of BMI and waist circumference on these associations among adults with normal glucose tolerance and with prediabetes. METHODS: In this nationwide, population-based, prospective cohort study, we analysed data from the China Cardiometabolic Disease and Cancer Cohort Study, which recruited adults aged 40 years or older during 2011-12 (baseline) and invited participants to attend follow-up visits in 2014-16. Patients with diabetes at baseline, missing data for baseline measures of glucose tolerance status, missing data for baseline homoeostasis model assessment (HOMA) indexes, missing data for baseline covariates, and missing data for measures of glucose tolerance status at follow-up visits were excluded. At baseline and follow-up visits, a comprehensive set of questionnaires, clinical measurements, oral glucose tolerance tests, and laboratory examinations were carried out following standardised protocols. Glucose tolerance status and prediabetes were defined according to the American Diabetes Association 2010 criteria. In the main analysis, we examined the contributions of insulin resistance (HOMA of insulin resistance [HOMA-IR]) and β-cell dysfunction (HOMA of β-cell function [HOMA-B]) to diabetes risk, and evaluated the impact of obesity on these associations. FINDINGS: 94 952 participants (31 517 men and 63 435 women) were included in the analysis. High HOMA-IR was associated with a greater hazard of diabetes (quartile 4 vs 1: hazard ratio [HR] 6·70, 95% CI 6·08-7·39; per unit increase in Z score: HR 2·17, 95% CI 2·10-2·24) than low HOMA-B (quartile 1 vs 4: 4·08, 3·72-4·48; per unit decrease in Z score: 1·92, 1·85-2·00). Approximately 24·4% (95% CI 23·6-25·2) of the incident diabetes could be attributed to insulin resistance and 12·4% (11·2-13·7) could be attributed to β-cell dysfunction. The HRs for diabetes were 1·83 (95% CI 1·72-1·95) per unit increase in Z score of HOMA-IR and 2·03 (1·86-2·21) per unit decrease in Z score of HOMA-B among participants with normal weight; the corresponding HRs for diabetes were 2·02 (1·93-2·11) and 1·88 (1·79-1·98) among participants with obesity (pinteraction=0·0091). These associations and interactions were similar for participants with normal glucose tolerance or prediabetes. INTERPRETATION: Insulin resistance shows a stronger association with incident diabetes than does β-cell dysfunction in Chinese adults, and this association pattern was more prominent among adults with obesity. Given the limitations of HOMA indexes as surrogate measures of insulin resistance and β-cell dysfunction, these findings should be interpreted with caution. FUNDING: National Natural Science Foundation of China.
引用
- Wang T, Lu J, Shi L, et al. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol. 2019. PMID: 31879247. doi:10.1016/S2213-8587(19)30425-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。